Beijing Hotgen Biotech Co., Ltd. (688068.SS)
CNY 52.76
(-1.59%)
CNY 52.76
(-1.59%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 7.76 Million CNY | -45.26% |
| 2022 | 14.18 Million CNY | -38.27% |
| 2021 | 22.97 Million CNY | 35.04% |
| 2020 | 17.01 Million CNY | -19.93% |
| 2019 | 21.25 Million CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | -100.0% |
| 2016 | 172.58 Thousand CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 3.34 Million CNY | 0.0% |
| 2024 Q1 | 6.97 Million CNY | 0.0% |
| 2024 Q3 | - CNY | 0.0% |
| 2023 Q1 | 15.81 Million CNY | 11.53% |
| 2023 Q2 | 10.39 Million CNY | -34.28% |
| 2023 Q4 | 7.76 Million CNY | -38.37% |
| 2023 Q3 | 12.59 Million CNY | 21.17% |
| 2023 FY | 7.76 Million CNY | -45.26% |
| 2022 Q4 | 14.18 Million CNY | -20.02% |
| 2022 Q3 | 17.73 Million CNY | -13.56% |
| 2022 Q1 | 24.54 Million CNY | 6.81% |
| 2022 Q2 | 20.51 Million CNY | -16.41% |
| 2022 FY | 14.18 Million CNY | -38.27% |
| 2021 Q2 | 15.78 Million CNY | -37.52% |
| 2021 Q1 | 25.26 Million CNY | 48.47% |
| 2021 FY | 22.97 Million CNY | 35.04% |
| 2021 Q3 | 13.17 Million CNY | -16.54% |
| 2021 Q4 | 22.97 Million CNY | 74.4% |
| 2020 FY | 17.01 Million CNY | -19.93% |
| 2020 Q2 | - CNY | -100.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q4 | 17.01 Million CNY | 0.0% |
| 2020 Q1 | 21.25 Million CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 FY | 21.25 Million CNY | 0.0% |
| 2019 Q4 | 21.25 Million CNY | 0.66% |
| 2019 Q3 | 21.11 Million CNY | 0.18% |
| 2019 Q2 | 21.07 Million CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2017 FY | - CNY | -100.0% |
| 2016 FY | 172.58 Thousand CNY | 0.0% |